Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fry

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Journal of Biological Chemistry|May 27, 2016
Crystal Structures of the Human Doublecortin C- and N-terminal Domains in Complex with Specific AntibodiesDominique Burger, Martine Stihle, Ashwani Sharma, et al.
Cancer Research|February 19, 2008
A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavageSherif Daouti, Wen-hui Li, Hong Qian, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2016
Mitigation of reactive metabolite formation for a series of 3-amino-2-pyridone inhibitors of Bruton's tyrosine kinase (BTK)Yan Lou, Francisco Lopez, Yongying Jiang, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Journal of Biological Chemistry|May 27, 2016
Crystal Structures of the Human Doublecortin C- and N-terminal Domains in Complex with Specific AntibodiesDominique Burger, Martine Stihle, Ashwani Sharma, et al.
Cancer Research|February 19, 2008
A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavageSherif Daouti, Wen-hui Li, Hong Qian, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2016
Mitigation of reactive metabolite formation for a series of 3-amino-2-pyridone inhibitors of Bruton's tyrosine kinase (BTK)Yan Lou, Francisco Lopez, Yongying Jiang, et al.
Pageof 3